Clearbridge Health (1H3.SI) Stock Price
Clearbridge Health Price
Revenue has compounded at 41.8% per year over the past 11 years to 9.93 M SGD. Earnings per share have declined at 1.5% per year over the last 6 years. Clearbridge Health's net margin stands at -130.0%, down from -58.5% several years earlier.
Clearbridge Health stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Clearbridge Health business model & stock analysis
Frequently asked questions about Clearbridge Health
The business model of Clearbridge Health Ltd revolves around providing integrated healthcare services and medical technology solutions. Clearbridge Health aims to enhance medical outcomes and deliver personalized patient care through its network of clinics and diagnostic centers across Asia. The company focuses on precision medicine, leveraging advanced diagnostics, medical imaging, and innovative digital platforms to enable early disease detection, diagnosis, and treatment. By combining cutting-edge technology with a patient-centric approach, Clearbridge Health strives to improve healthcare accessibility and deliver sustainable growth in the rapidly evolving healthcare industry.
Clearbridge Health Ltd is primarily active in the healthcare industry.
The main competitors of Clearbridge Health Ltd in the market include companies such as AITbiotech Pte Ltd, Cordlife Group Limited, and Q&M Dental Group.
Clearbridge Health Ltd is a leading healthcare company with a rich history and background. Established in [year], Clearbridge Health has emerged as a trusted player in the industry, offering innovative healthcare solutions and services. The company specializes in precision medicine, providing advanced diagnostic and molecular testing, biobanking, and telemedicine services. With an extensive network of medical professionals and strategic partnerships, Clearbridge Health is committed to delivering personalized healthcare solutions to patients. Its dedication towards technological advancements, research, and quality patient care has positioned Clearbridge Health Ltd as a prominent player in the healthcare sector.
Clearbridge Health Ltd has achieved significant milestones in its growth and development. The company has expanded its presence in the healthcare industry by establishing strategic partnerships and making successful acquisitions. Clearbridge Health Ltd has also achieved notable financial milestones, demonstrating its strong performance and growth potential. Additionally, the company has received recognition for its innovative solutions and commitment to delivering high-quality healthcare services. These achievements showcase Clearbridge Health Ltd's dedication to driving positive change in the healthcare sector and establishing itself as a leading player in the industry.
Clearbridge Health Ltd is primarily present in Singapore and Malaysia.
Clearbridge Health Ltd represents a strong commitment to delivering quality healthcare solutions. The company's corporate philosophy revolves around innovation, integrity, and patient-centric care. They strive to provide advanced medical technologies and services that meet the ever-growing needs of patients and healthcare professionals. Clearbridge Health Ltd aims to improve wellness and healthcare outcomes by leveraging cutting-edge diagnostic and therapeutic solutions. Their dedication to research and development, along with strategic partnerships, allows them to stay at the forefront of the healthcare industry. By prioritizing customer satisfaction and long-term value creation, Clearbridge Health Ltd continues to establish itself as a trusted leader in the healthcare sector.
5 analysts currently rate the Clearbridge Health stock: 4 recommend buying, 1 holding and 0 selling.
Converted at the current exchange rate, the Clearbridge Health share trades at 0.00 EUR (0.00 SGD).
Clearbridge Health Ltd is a leading company in the healthcare sector with the aim of improving the diagnosis and treatment of various diseases through the use of advanced technologies and services. The company operates in various divisions, including healthcare management, diagnosis and pathology, and medical devices. Clearbridge Health offers comprehensive services in healthcare management to meet the need for high-quality care and support. The company has developed a digital health platform that allows patients to manage their health data and communicate with doctors and medical professionals. By utilizing artificial intelligence and data analysis, Clearbridge Health has also developed a software solution to better manage medical records and make decisions. These algorithms support doctors in decision-making and aid in disease detection and prediction. In the field of diagnosis and pathology, Clearbridge Health provides a wide range of services that focus on accurate disease diagnosis. The company has developed an innovative method for detecting cancer based on sequencing tumor cells, enabling precise diagnosis. Clearbridge Health has also developed an extensive range of medical devices and is capable of supplying both clinical and home devices. These medical devices enable medical personnel to achieve fast and accurate results, facilitating quick and effective diagnoses and therapies. To improve its services and stay up to date with the latest technology, Clearbridge Health has entered into strategic partnerships with leading companies in the healthcare sector worldwide. This collaboration has helped Clearbridge Health become a market leader with its products and services. The business model of Clearbridge Health is focused on providing a comprehensive range of services and products to meet the need for high-quality care and support. The company relies on advanced technologies to achieve accurate and fast results, as well as first-class medical professionals who are able to provide optimal care to their patients. In summary, Clearbridge Health is an innovative company in the healthcare sector that contributes to improving the health and well-being of people through its use of advanced technologies and services. The company is on a growth trajectory and has already introduced a wide range of products and services tailored to the requirements of modern healthcare.
The revenue cannot currently be calculated for Clearbridge Health.
The profit cannot currently be calculated for Clearbridge Health.
The P/E ratio cannot be calculated for Clearbridge Health at the moment.
The P/S cannot be calculated for Clearbridge Health currently.
The Eulerpool Quality Score for Clearbridge Health is 3/10.
The ISIN of Clearbridge Health is SG1EB6000000. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Clearbridge Health is A2P5MF. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Clearbridge Health is 1H3.SI. The ticker symbol is used to trade Clearbridge Health shares on the stock exchange.
Clearbridge Health stock
Clearbridge Health Peer Group
Clearbridge Health FIGI
All fundamentals and in-depth analysis of Clearbridge Health
Our stock analysis for Clearbridge Health stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Clearbridge Health. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.